denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Program: Education Program
Session: Advances in the Laboratory Assessment of Hemostatic and Thrombotic Disorders
Hematology Disease Topics & Pathways:
apheresis, Diseases, Bleeding and Clotting, Technology and Procedures, Clinically relevant, Quality Improvement , TTP, serologic tests
Session: Advances in the Laboratory Assessment of Hemostatic and Thrombotic Disorders
Hematology Disease Topics & Pathways:
apheresis, Diseases, Bleeding and Clotting, Technology and Procedures, Clinically relevant, Quality Improvement , TTP, serologic tests
Saturday, December 5, 2020, 7:25 AM-7:30 AM
Disclosures: Kremer Hovinga Strebel: SHIRE/TAKEDA: Membership on an entity's Board of Directors or advisory committees, Other: advisory board, Research Funding; Ablynx/Sanofi: Other: Advisory Board, Speakers Bureau; Shire/Takeda: Other: Advisory Board, Research Funding; CSL Behring: Speakers Bureau; Roche: Speakers Bureau; Siemens: Speakers Bureau; Ablynx/Sanofi: Membership on an entity's Board of Directors or advisory committees, Other: advisory board, Speakers Bureau.
OffLabel Disclosure: potential discussion of off-label drug use: use of Rituximab in immune-mediated TTP
See more of: Advances in the Laboratory Assessment of Hemostatic and Thrombotic Disorders
See more of: Education Program
See more of: Education Program
Previous Presentation
|
Next Presentation >>